The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Warrants

26 Mar 2020 07:00

RNS Number : 6342H
Location Sciences Group PLC
26 March 2020
 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

Issue of Warrants

 

Location Sciences (AIM: LSAI), the leading location data verification company, announces that it has agreed to issue warrants to subscribe for up to, in aggregate, 74,286,667 New Ordinary Shares at an exercise price of 0.1 pence per New Ordinary Share (the "Warrants").

 

The Warrants, which will be issued conditional upon Admission, will be issued to all Placees participating in the Placing to raise approximately £0.975 million announced by the Company on 6 March 2020. Each Placee will receive two Warrants for every three Placing Shares subscribed. The Warrants are exercisable at 0.1 pence per New Ordinary Share during the period from Admission until 30 June 2020, with any unexercised Warrants lapsing following this date. The Warrants will be issued in certificated form and will not be transferable. It is anticipated that certificates for the Warrants will be posted to Placees by no later than 10 Business Days after Admission. No application will be made for the Warrants to be admitted to trading on AIM.

 

Background to, and reasons for, the issue of the Warrants

 

On 6 March 2020, the Company announced that it had conditionally raised approximately £0.975 million (before expenses) through a Placing comprising the issue and allotment of 111,430,000 New Ordinary Shares at an issue price of 0.875 pence per New Ordinary Share ("Issue Price"). 

 

The Issue Price represented a discount of 37.5 per cent. to the closing mid-market price of 1.4 pence per Existing Ordinary Share on 5 March 2020. However, since the Company's announcement on 6 March 2020, there have been adverse financial market conditions due to the COVID-19 pandemic which has seen global share prices reduce. As a consequence, the Company's closing mid-market price on 25 March 2020 was 0.575 pence per Existing Ordinary Share, being approximately 35 per cent. below the Issue Price. In these unprecedented circumstances, the Board has taken the decision to secure the success of the Placing through the issue of the Warrants which, if fully exercised, reduces the Issue Price to the equivalent of 0.565 pence per New Ordinary Share.

 

If all of the Warrants are exercised, the gross proceeds receivable by the Company would be £74,287, bringing the aggregate value of the fundraising, including the proceeds of the Placing, to approximately £1.05 million.

 

The issue of the Warrants will utilise the Company's existing share authorities put in place at the Company's annual general meeting held on 1 May 2019.

 

Mark Slade, Chief Executive Officer of Location Sciences, commented: "The impact of COVID-19 on the financial markets has been profound, which has resulted in our share price falling well below the Issue Price and, as a consequence, we have had to try to balance the interests of Placees with what is best for the Company.

 

This is clearly not something we, as Directors, take lightly and we are deeply aware that this Placing impacts our existing loyal Shareholders. However, we do hope Shareholders will appreciate that it provides the funding the business needs and gives us the ability to keep growing. Thank you to all those who have shown us support; we will continue to work night and day to build value for you all. I do hope some of you can attend today's General Meeting virtually so I can answer your questions directly."

 

 

Terms used in this announcement but not otherwise defined have the meanings given to them in the Circular.

 

 

For further information please contact: 

 

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

Shore Capital (Nomad and Broker)

Tel: +44 (0)20 7408 4090

Tom Griffiths

 

David Coaten

 

 

 

Peterhouse Capital (Placing Agent)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

 

Milk & Honey PR

 Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

The person making this notification on behalf of the Company is David Rae, Chief Financial Officer of the Company.

 

About Location Sciences

Location Sciences is the pre-eminent global location verification provider to the $190 billion digital advertising industry, working in partnership with brands, media agencies and suppliers to reduce ad wastage and improve the effectiveness of location-based advertising campaigns. 

 

The digital advertising marketplace remains unregulated and unmonitored, with an estimated $19 billion wasted on ad fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLFEAVRIEFII
Date   Source Headline
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSResult of Broker Option
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
4th May 202111:05 amRNSSecond Price Monitoring Extn
4th May 202111:00 amRNSPrice Monitoring Extension
4th May 20219:05 amRNSSecond Price Monitoring Extn
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:00 amRNSProposed Fundraise of up to £3.85m - Notice of GM
23rd Apr 20212:05 pmRNSSecond Price Monitoring Extn
23rd Apr 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSFinal Results for the year ended 31 December 2020
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 202111:00 amRNSPrice Monitoring Extension
19th Feb 20213:36 pmRNSTR-1 Notification of major holdings
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 20219:05 amRNSSecond Price Monitoring Extn
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSTrading Update and Directorate Changes
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20214:40 pmRNSSecond Price Monitoring Extn
20th Jan 20214:35 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20204:41 pmRNSSecond Price Monitoring Extn
17th Dec 20204:35 pmRNSPrice Monitoring Extension
16th Dec 20204:41 pmRNSSecond Price Monitoring Extn
16th Dec 20204:36 pmRNSPrice Monitoring Extension
14th Dec 20207:00 amRNSPotential Defamation Action Against the Company
30th Nov 20207:00 amRNSNew Contract Win and Trading Update
5th Nov 20203:44 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSIssue of shares to directors in lieu of fees & TVR
1st Oct 20207:00 amRNSAppointment of Nominated Adviser
17th Sep 202012:43 pmRNSHalf-year Report - Replacement
15th Sep 20207:00 amRNSHalf-year Report
1st Sep 20209:05 amRNSSecond Price Monitoring Extn
1st Sep 20209:00 amRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSContract
27th Jul 20207:00 amRNSTrading Update
3rd Jul 202011:05 amRNSSecond Price Monitoring Extn
3rd Jul 202011:00 amRNSPrice Monitoring Extension
1st Jul 202010:02 amRNSIssue of Equity and Total Voting Rights
16th Jun 202010:36 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.